• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芬兰药品的多用途使用情况。

Multiuse of medicines in Finland.

作者信息

Klaukka T, Mäkelä M, Sipilä J, Martikainen J

机构信息

Social Insurance Institution, Helsinki, Finland.

出版信息

Med Care. 1993 May;31(5):445-50. doi: 10.1097/00005650-199305000-00006.

DOI:10.1097/00005650-199305000-00006
PMID:8501991
Abstract

The purpose of this study was to investigate the occurrence of multiuse of prescription drugs and its major determinants among Finnish adults. The data were based on three nationally representative and intercomparable health surveys in 1976, 1978-80, and 1987. The study populations were 16,413 in 1976, 13,138 in 1987, and 7,217 in 1978-80. The simultaneous use of at least five prescription drugs was the main outcome measure. In 1976, 4.7% of the study population, and 6.3% in 1987 were multiusers. Of all users of prescription drugs, the proportion of multiusers was 14% both in 1976 and 1987. In 1987, the elderly comprised 55% of all multiusers, whereas their share in 1976 was 44%. The strongest predictor of the multiuse was, as expected, chronic morbidity. Of the various diagnostic groups, the main determinants were cardiac insufficiency, hypertension, asthma, mental disorders, and coronary heart disease. Even allowing for chronic morbidity, age was significantly associated with multiuse, but sex was not. The number of visits to a primary care physician correlated also independently with the multiuse. These findings indicate that the elderly may in part get prescriptions indiscriminately.

摘要

本研究旨在调查芬兰成年人中处方药多药联用的情况及其主要决定因素。数据基于1976年、1978 - 1980年以及1987年三项具有全国代表性且可相互比较的健康调查。1976年的研究人群有16413人,1987年有13138人,1978 - 1980年有7217人。主要的结局指标是同时使用至少五种处方药。1976年,4.7%的研究人群为多药联用者,1987年这一比例为6.3%。在所有处方药使用者中,1976年和1987年多药联用者的比例均为14%。1987年,老年人占所有多药联用者的55%,而1976年他们的占比为44%。正如预期的那样,多药联用的最强预测因素是慢性病发病率。在各个诊断组中,主要决定因素是心功能不全、高血压、哮喘、精神障碍和冠心病。即使考虑到慢性病发病率,年龄与多药联用也显著相关,但性别则不然。到初级保健医生处就诊的次数也与多药联用独立相关。这些发现表明,老年人可能在一定程度上会不加区分地获取处方。

相似文献

1
Multiuse of medicines in Finland.芬兰药品的多用途使用情况。
Med Care. 1993 May;31(5):445-50. doi: 10.1097/00005650-199305000-00006.
2
Users of prescription drugs in Finnish primary care.
Scand J Prim Health Care. 1988 Feb;6(1):43-50. doi: 10.3109/02813438809009289.
3
Change in determinants of use of physician services in Finland between 1987 and 1996.1987年至1996年间芬兰医生服务使用决定因素的变化。
Soc Sci Med. 2002 Nov;55(9):1523-37. doi: 10.1016/s0277-9536(01)00285-4.
4
Clinical, social and relational determinants of paediatric ambulatory drug prescriptions due to respiratory tract infections in Italy.意大利儿童因呼吸道感染进行门诊药物处方的临床、社会及关系决定因素
Eur J Clin Pharmacol. 2006 Dec;62(12):1055-64. doi: 10.1007/s00228-006-0198-8. Epub 2006 Oct 5.
5
Who is using antihypertensive drugs? A prescription analysis from Finland.谁在使用降压药?来自芬兰的一项处方分析。
Scand J Prim Health Care. 1996 Mar;14(1):54-61. doi: 10.3109/02813439608997069.
6
Chronic non-cancer pain and the epidemic prescription of opioids in the Danish population: trends from 2000 to 2013.丹麦人群中的慢性非癌性疼痛与阿片类药物的流行处方:2000年至2013年的趋势
Acta Anaesthesiol Scand. 2016 May;60(5):623-33. doi: 10.1111/aas.12700. Epub 2016 Feb 9.
7
Prescription of drugs during pregnancy in France.法国孕期用药处方
Lancet. 2000 Nov 18;356(9243):1735-6. doi: 10.1016/s0140-6736(00)03209-8.
8
Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999.门诊处方中与潜在药物相互作用相关的绝对禁忌证:对1999年最初500万张处方的分析
Eur J Clin Pharmacol. 2004 Feb;59(12):899-904. doi: 10.1007/s00228-003-0709-9. Epub 2003 Dec 19.
9
Effect of therapeutic class on counseling in community pharmacies.治疗类别对社区药房咨询服务的影响。
Ann Pharmacother. 2002 May;36(5):781-6. doi: 10.1345/aph.1A374.
10
Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City.墨西哥城家庭医学诊所中50岁以上门诊患者处方中的潜在药物相互作用及药物与疾病相互作用
BMC Health Serv Res. 2007 Sep 19;7:147. doi: 10.1186/1472-6963-7-147.

引用本文的文献

1
Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis.老年人的用药模式以及与多重用药和过度多重用药相关的因素:库奥皮奥75岁及以上研究结果:一项横断面分析
Drugs Aging. 2009;26(6):493-503. doi: 10.2165/00002512-200926060-00006.
2
Polypharmacy among disabled Taiwanese elderly: a longitudinal observational study.台湾残疾老年人的多重用药情况:一项纵向观察研究。
Drugs Aging. 2009;26(4):345-54. doi: 10.2165/00002512-200926040-00005.
3
Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years.
强制通用名替代对药品销售模式的影响:一项为期五年的全国性研究。
BMC Health Serv Res. 2008 Feb 29;8:50. doi: 10.1186/1472-6963-8-50.
4
[Prescription of drugs in family medicine: on the trail of efficiency].[家庭医学中的药物处方:探寻疗效]
Aten Primaria. 2004 Sep 15;34(4):178-85. doi: 10.1016/s0212-6567(04)78905-2.
5
Awareness of the side effects of possessed medications in a community setting.社区环境中对现有药物副作用的认知。
Eur J Clin Pharmacol. 2003 Apr;58(12):821-7. doi: 10.1007/s00228-003-0570-x. Epub 2003 Mar 7.
6
Is it possible to reduce polypharmacy in the elderly? A randomised, controlled trial.是否有可能减少老年人的多重用药情况?一项随机对照试验。
Drugs Aging. 2001;18(2):143-9. doi: 10.2165/00002512-200118020-00007.
7
Antacid (A02A) and antiulcer (A02B) drug prescription patterns: predicting factors, dosage and treatment duration.抗酸剂(A02A)和抗溃疡药(A02B)的处方模式:预测因素、剂量及治疗持续时间
Eur J Epidemiol. 1998 Jun;14(4):363-72. doi: 10.1023/a:1007493003891.
8
Hypertension registry as the base for population health care.
J Med Syst. 1996 Apr;20(2):111-28. doi: 10.1007/BF02260895.
9
Information on drug use in the elderly: a comparison of pharmacy, general-practitioner and patient data.
Pharm World Sci. 1995 Jan 27;17(1):20-4. doi: 10.1007/BF01875554.